USPTO serial 75736611
PASTEUR FOUNDATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUTLER, ANDREA P
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PASTEUR FOUNDATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
75724 Paris Cedex 15, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Edward E. Vassallo
EDWARD E VASSALLO FITZPATRICK, CELLA, HARPER & SCINTO30 ROCKEFELLER PLZNEW YORK, NY 10112UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical used in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | bacterial poisons for use in the treatment or prevention of infectious and systemic diseases in humans and animals; bacterial preparations for medical and veterinary use for treatment or prevention of infectious and systemic diseases in humans and animals; bacteriological purpose for medical and veterinary use for in treatment or prevention of infectious and systemic diseases in humans and animals; biological preparations for treatment of prevention of infectious and systemic diseases in humans and animals; bismuth preparations for pharmaceutical purposes; cachets for pharmaceutical purpose; unit dose capsules for pharmaceuticals purpose sold empty for pharmaceutical use; gelatin capsules sold empty for pharmaceuticals; chemical preparations used in the manufacture of products used in the treatment or prevention of infectious or systemic diseases; chemical preparations used in the manufacture of products used in the treatment or prevention or prevention of infectious or systemic diseases; chemical preparations used in the manufacture of products used in the treatment or prevention of infectious or systemic diseases; for pharmaceutical purposes; chemico pharmaceutical preparations for the treatment or prevention of infectious and systemic diseases in humans and animals; cream of tartar used in the manufacture of or treatment of prevention of infectious and systemic diseases in humans and animals; cultures of micro organisms for medical and veterinary use for the treatment of prevention of infectious and systemic diseases in humans and animals; dicoctions for use in the treatment of humans or animals diseases detergents for the elimination of microbial contaminations diagnostic preparations, namely; immuno-diagnostic preparations or biology diagnostic preparations for the detection and survey of infectious systemic and systemic diseases in humans or animals elixirs for the treatment of infectious, systemic or genetic diseases in human, animals and plants, enzyme preparation for the treatment of infectious, systemic and genetic diseases in humans, animals and plants enzymes for the treatment of infectious, systemic and genetic diseases in humans, animals and plants; hormones, nutritive substances for micro-organisms and cell cultures; antibiotic ointments, pastilles, pharmaceutical preparations, namely pomades for use in the treatment of infectious or systemic diseases in humans and animals serums for the treatment of infectious diseases in human and animals chemical reagents for testing the sterility of pharmaceuticals and injectable solutions for medical or veterinary purposes | ACTIVE | — |
| 016 | books, magazines and newspapers featuring pharmaceutical preparations | ACTIVE | — |
| 041 | publications of books, magazines, and newspapers; educational services, namely, arranging and organizing educational services, namely, barraging and organizing educational activities, academic seminars, appearance of speakers, seminars on special topics, meeting, and expert technical analysis, all in the field of chemistry biochemistry and biology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Institut Pasteur
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 041
- Similar marks named PASTEUR FOUNDATION
- Prosecution event ABN2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 13, 2001 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 18, 2000 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 31, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 1999 | DOCK | ASSIGNED TO EXAMINER | — |